Preimplantation Genetics, a revolutionary field in reproductive medicine, has transformed the landscape of assisted reproductive technologies, offering a profound understanding and control over the genetic makeup of embryos before implantation. This cutting-edge technique, often referred to as Preimplantation Genetic Testing (PGT), empowers individuals and couples to make informed decisions about their family planning journey, particularly in the context of hereditary genetic conditions. Preimplantation genetics tries to discover and choose embryos with the desired genetic features by doing genetic analysis on embryos formed through in vitro fertilisation (IVF) prior to implantation, thereby reducing the danger of passing down inheritable illnesses to future generations. The primary motivation behind the adoption of preimplantation genetics lies in its potential to prevent the transmission of genetic diseases. Couples carrying a known genetic disorder, be it a single gene disorder like cystic fibrosis or a chromosomal abnormality, face the daunting prospect of passing on the condition to their offspring. Preimplantation Genetic Testing allows these individuals to undergo IVF, and during the early stages of embryo development, a few cells are extracted and analyzed for genetic abnormalities. Only embryos deemed free of the targeted genetic disorder are then selected for implantation, offering a significantly enhanced chance of having a healthy child. Beyond the prevention of genetic diseases, preimplantation genetics plays a pivotal role in fertility treatment by addressing issues such as recurrent pregnancy loss and advanced maternal age. As women age, the risk of chromosomal abnormalities in their eggs increases, leading to a higher likelihood of miscarriage and conditions such as Down syndrome. Preimplantation Genetic Testing for Aneuploidy (PGT-A) evaluates embryos for chromosomal abnormalities, allowing clinicians to select embryos with the correct number of chromosomes, thereby improving the chances of a successful pregnancy and a healthy baby. Preimplantation genetics also extends its applications to family balancing or gender selection, a controversial but increasingly sought-after option by parents aspiring to balance the gender composition of their offspring. By identifying embryos of a specific gender during the genetic testing process, individuals or couples can make more informed choices about family planning, aligning with their preferences or addressing gender-specific genetic conditions.
Title : Male factors in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : Understanding pelvic organ prolapse
Woojin Chong, NYU Langone Medical Center, United States
Title : Efficacy of full piers calculator in predicting adverse maternal outcomes in preeclampsia at a tertiary care hospital in South India
Sangeetha Shah, Osmania Medical College, India
Title : Pulmonary embolism in pregnancy
Orfanoudaki Irene, University Hospital of Heraklion, Greece
Title : Role of artificial intelligence in the diagnosis and management of endometriosis. The prospect of the future
Mohamed Hosni, London North West University Hospitals, United Kingdom
Title : Vaginal colonization by uropathogenic microorganisms: A key contributor to reproductive failure in mice
Vijay Prabha, Panjab University, India